HCA Healthcare, Inc.
HCA
$486.70
-$0.96-0.20%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.16B | 18.61B | 18.32B | 18.29B | 17.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.16B | 18.61B | 18.32B | 18.29B | 17.49B |
| Cost of Revenue | 11.15B | 10.98B | 10.76B | 10.71B | 10.52B |
| Gross Profit | 8.02B | 7.62B | 7.56B | 7.58B | 6.97B |
| SG&A Expenses | -- | -- | -- | 1.05B | -- |
| Depreciation & Amortization | 889.00M | 863.00M | 860.00M | 856.00M | 842.00M |
| Other Operating Expenses | 4.16B | 3.79B | 3.85B | 2.82B | 3.72B |
| Total Operating Expenses | 16.20B | 15.64B | 15.47B | 15.44B | 15.08B |
| Operating Income | 2.97B | 2.97B | 2.86B | 2.85B | 2.41B |
| Income Before Tax | 2.42B | 2.42B | 2.33B | 2.13B | 1.91B |
| Income Tax Expenses | 515.00M | 524.00M | 502.00M | 447.00M | 424.00M |
| Earnings from Continuing Operations | 1.90B | 1.89B | 1.83B | 1.69B | 1.48B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -260.00M | -238.00M | -215.00M | -248.00M | -212.00M |
| Net Income | 1.64B | 1.65B | 1.61B | 1.44B | 1.27B |
| EBIT | 2.97B | 2.97B | 2.86B | 2.85B | 2.41B |
| EBITDA | 3.85B | 3.83B | 3.72B | 3.70B | 3.25B |
| EPS Basic | 7.05 | 6.91 | 6.52 | 5.63 | 4.95 |
| Normalized Basic EPS | 5.38 | 5.32 | 5.02 | 4.73 | 3.82 |
| EPS Diluted | 6.96 | 6.83 | 6.45 | 5.63 | 4.88 |
| Normalized Diluted EPS | 5.30 | 5.26 | 4.97 | 4.73 | 3.78 |
| Average Basic Shares Outstanding | 232.89M | 239.17M | 246.94M | 255.31M | 256.76M |
| Average Diluted Shares Outstanding | 236.18M | 241.91M | 249.44M | 255.31M | 259.92M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.66 | 0.66 |
| Payout Ratio | 10.10% | 10.34% | 11.18% | 11.47% | 13.31% |